Current guidelines for oxygen therapy in emergency care


Cite item

Full Text

Abstract

Hypoxemia can cause damage to any tissue in the human body. Tissue hypoxia is a condition in which oxygen (O2) delivery to the tissues does not meet their metabolic needs. The major goal in the treatment of patients with hypoxemic acute respiratory failure (ARF) is to ensure normal oxygenation of the body. The leading therapy option for ARF is the use of O2. The paper gives the basic principles of emergency O2 therapy: indications, treatment goals, monitoring guidelines, methods for delivery of O­2, and measures to prevent its toxic effects.

Full Text

Современные рекомендации по неотложной кислородотерапии. - Аннотация. Гипоксемия способна приводить к повреждению любой ткани человеческого организма. Тканевая гипоксия - состояние, при котором доставка кислорода (О2) к тканям не соответствует их метаболическим потребностям. Главная задача лечения пациентов с гипоксемической острой дыхательной недостаточностью (ОДН) состоит в обеспечении нормальной оксигенации организма. Ведущим методом терапии ОДН является назначение О2. В статье представлены основные принципы ургентной кислородотерапии: показания, задачи лечения, рекомендации по мониторингу, методы доставки О2 и мероприятия по профилактике его токсических эффектов.
×

About the authors

S N Avdeev

Email: serg_avdeev@list.ru

References

  1. West J.B. Pulmonary Pathophysiology. Baltimore: Williams & Wilkins 1998; 198.
  2. Зильбер А.П. Дыхательная недостаточность. М: Медицина 1989; 512.
  3. O'Connor M., Hall J.B., Schmidt G.A. et al. Acute hypoxemic respiratory failure. In: Principles of Critical Care. Eds. J.B. Hall, G.A. Schmidt, L.D.H. Wood. New York: McGraw-Hill Publishers 1998; 537-559.
  4. Gutierrez G. Cellular effects of hypoxemia and ischemia. In: The Lung: Scientific Foundations. Eds. R.G. Crystal, J.B. West, E.R. Weibel, P.J. Barnes. 2nd ed. Philadelphia: Lippincott-Raven Publishers 1997; 1969.
  5. Hornbein T.F. Hypoxia and the brain. In: The Lung: Scientific Foundations. 2nd ed. Eds. R.G. Crystal, J.B. West, E.R. Weibel, P.J. Barnes. Philadelphia: Lippincott-Raven Publishers 1997; 1981.
  6. Snider G.L., Fairley H.B., Palmer J.D., Weg J.C. Scientific basis of oxygen therapy. Chest 1984; 86: 236-239.
  7. McNichol M.W., Campbell E.J.M. Severity of respiratory failure. Lancet 1965; i: 336-338.
  8. Anthonisen N.R. Hypoxemia and O2 therapy. Am Rev Respir Dis 1982; 126: 729-733.
  9. Авдеев С.Н. Дыхательная недостаточность: определение, классификация, подходы к диагностике и терапии. В кн: Респираторная медицина. Руководство. Под ред. А.Г. Чучалина. Т. 2. М: ГЭОТАР-Медиа 2007; 658-668.
  10. Bateman N.T., Leach R.M. ABC of oxygen: acute oxygen therapy. Br Med J 1998; 317: 798-798.
  11. Fulmer J.D., Snider G.L. ACCP-NHLBI National Conference on Oxygen Therapy. Chest 1984; 86: 234-247.
  12. American Association for Respiratory Care: Clinical Practice Guideline. Oxygen Therapy for Adults in the Acute Care Facility - 2002 Revision & Update. Respir Care 2002; 47: 717-720.
  13. Davidson C., Treacher D. Respiratory Critical Care. London: Arnold 2002; 307.
  14. Kirby R.R., Taylor R.W. Respiratory failure. Chicago: Year Book Medical Publishers Inc 1988; 665.
  15. Chronos N., Adams L., Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin Sci (Lond) 1988; 74: 531-537.
  16. Lane R., Cockcroft A., Adams L., Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci (Lond) 1987; 72: 693-698.
  17. Swinburn C.R., Mould H., Stone T.N. et al. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis 1991; 143: 913-915.
  18. Somfay A., Porszasz J., Lee S.M., Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001; 18: 77-84.
  19. O'Donnell D.E., D'Arsigny C., Webb K.A. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-898.
  20. Dean N.C., Brown J.K., Himelman R.B. et al. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis 1992; 146: 941-945.
  21. Manning H.L., Schwartzstein R.M. Pathophysiology of dyspnea. N Engl J Med 1995; 333: 1547-1553.
  22. Criner G.J., Celli B.R. Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia. J Appl Physiol 1987; 63: 195-200.
  23. Bye P.T., Esau S.A., Levy R.D. et al. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am Rev Respir Dis 1985; 132: 236-240.
  24. Barth E., Bassi G., Maybauer D.M. et al. Effect of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med 2008; 36: 495-503.
  25. Sharkey R.A., Mulloy E.M.T., O'Neill S.J. The acute effects of oxygen and carbon dioxide on renal vascular resistance in patients with an acute exacerbation of COPD. Chest 1999; 115: 1588-1592.
  26. Shapiro B.A., Peruzzi W.T., Templin R.K. Clinical Application of Blood Gases, 5th ed. St. Louis: CV Mosby 1994: 127-156.
  27. Cairo J.M. Administering medical gases: regulators, flow meters and controlling devices. In: Respiratory Care Equipment. Eds. J.M. Cairo, S.P. Pilbeam. St. Louis: CV Mosby 1999; 62- 89.
  28. Costello R.W., Liston R., McNicholas W.T. Compliance at night with low flow oxygen therapy: A comparison of nasal cannulae and Venturi face masks. Thorax 1995; 50: 405-406.
  29. Kacmarek R.M. Methods of oxygen delivery in the hospital. Probl Respir Care 1990; 3: 563-574.
  30. Gibson R.L., Comer P.B., Beckham R.W. et al. Actual transtracheal oxygen concentrations with commonly used oxygen equipment. Anesthesiology 1976; 44: 71-73.
  31. Schacter E.N., Littner M.R., Luddy P. et al. Monitoring of oxygen delivery systems in clinical practice. Crit Care Med 1980; 8: 405-409.
  32. Milross J., Young I.H., Donnelly P. The oxygen delivery characteristics of the Hudson Oxy-one face mask. Anaesth Intens Care 1989; 17: 180-184.
  33. Cooper N. Acute medicine: Treatment with oxygen. Br Med J 2004; 12: 56-58.
  34. Scacci R. Air-entrainment masks: Jet mixing is how they work; The Bernoulli and Venturi principles are how they don't. Respir Care 1979; 24: 928-931.
  35. Cox D., Gillbe C. Fixed performance oxygen masks. Anaesthesia 1981; 36: 958-964.
  36. Redding J.G., McAfee P.D., Parham A.M. Oxygen concentrations received from commonly used delivery systems. South Med J 1978; 71: 169-172.
  37. Waugh J.B., Granger W.M. An Evaluation of 2 New Devices for Nasal High-Flow Gas Therapy. Respir Care 2004; 49: 902-906.
  38. Tiep B., Barnett M. High flow nasal vs high flow mask oxygen deliver: tracheal gas concentrations through a head extension airway model (abstract). Respir Care 2002; 47: 1079.
  39. Tiffin N., Weinstein L., Fabyanic C., Whitescarver H. Comparison of current high flow oxygen humidification systems with a novel humidifier (Pari Hydrate™). ERS 2007; 1933.
  40. Monchi M. Comparison of the performance of 5 systems of spontaneous ventilation with CPAP on a mechanical lung. Thèse de Doctorat en Médecine, Université Paris VI. Paris (France) 1997.
  41. Maitre B.J.S., Maggiore S.M., Bergot E. et al. Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. A randomized double-blind study using a new device. Am J Respir Crit Care Med 2000; 162: 1063-1067.
  42. Moritz F., Benichou J., Vanheste M. et al. Boussignac continuous positive airway pressure device in the emergency care of acute cardiogenic pulmonary oedema: a randomized pilot study. Eur J Emerg Med 2003; 10: 204-208.
  43. Templier F., Dolveck F., Baer M. et al. Laboratory testing measurement of FiO2 delivered by Boussignac CPAP system with an input of 100% oxygen. Ann Fr Anesth Reanim 2003; 22: 103-107.
  44. Dieperink W., Jaarsma T., van der Horst I.C.C. et al. Boussignac continuous positive airway pressure for the management of acute cardiogenic pulmonary edema: prospective study with a retrospective control group. BMC Cardiovasc Dis 2007; 7: 40.
  45. Templier F.D.F., Baer M., Chauvin M., Fletcher D. 'Boussignac' continuous positive airway pressure system: practical use in a prehospital medical care unit. Eur J Emerg Med 2003; 10: 87-93.
  46. Eisenman A., Rusetski V., Sharivker D., Avital R.N. Role of the Boussignac Continuous Positive Pressure Mask in the Emergency Department. Israel J Emerg Med 2008; 8: 6-11.
  47. Woolf C.R. Arterial blood gas levels after oxygen therapy. Chest 1976; 69: 808-809.
  48. Bone R.C., Pierce A.K., Johnson R.L. Jr. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: a reappraisal. Am J Med 1978; 65: 896-902.
  49. Oxer H.F. Simply add oxygen: why isn't oxygen administration taught in all resuscitation training? Resuscitation 2000; 43: 163-169.
  50. Lambertsen C.J., Stroud M.W. III, Gould R.A. et al. Oxygen toxicity: respiratory responses of normal men to inhalation of 6 and 100 per cent oxygen under 3.5 atmospheres pressure. J Appl Physiol 1953; 5: 487-494.
  51. Becker H.F., Polo O., McNamara S.G. et al. Effect of different levels of hyperoxia on breathing in healthy subjects. J Appl Physiol 1996; 81: 1683-1690.
  52. Malhotra A., Schwartz D.R. Ayas N. et al. Treatment of oxygen-induced hypercapnia. Lancet 2001; 357: 884-885.
  53. Senior R.M., Wessler S., Avioli L.V. Pulmonary oxygen toxicity. JAMA 1971; 217: 1373-1378.
  54. Deneke S.M., Fanburg B.L. Normobaric oxygen toxicity of the lung. N Engl J Med 1980; 303: 76-86.
  55. Calfee C.S., Matthay M.A. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007; 131: 913-920.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies